- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.04. | VENUS MEDTECH-B (02500): NOTIFICATION LETTER TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT AND REPLY FORM | 2 | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT AND REPLY FORM | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2024 ANNUAL REPORT | 1 | HKEx | ||
| 22.04. | Venus Medtech (Hangzhou) Inc.: Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations | 309 | PR Newswire | HONG KONG, April 22, 2025 /PRNewswire/ -- Venus MedTech (Hangzhou) Inc. (Stock Code: 2500.HK, hereinafter referred to as "Venus Medtech" or the "Company"), a global leader in structural heart... ► Artikel lesen | |
| 28.03. | VENUS MEDTECH-B (02500): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 | - | HKEx | ||
| 20.03. | VENUS MEDTECH-B (02500): PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE | 2 | HKEx | ||
| 18.03. | VENUS MEDTECH-B (02500): DATE OF BOARD MEETING | - | HKEx | ||
| VENUS MEDTECH Aktie jetzt für 0€ handeln | |||||
| 14.03. | China's Venus Medtech Goes Live Again With 69% Plunge After Embezzlement | 1 | Yicai Global | ||
| 12.03. | VENUS MEDTECH-B (02500): FULFILLMENT OF ALL RESUMPTION GUIDANCE AND RESUMPTION OF TRADING | 1 | HKEx | ||
| 21.02. | VENUS MEDTECH-B (02500): (1) THE FIFTH QUARTERLY UPDATE ON RESUMPTION PROGRESS; AND (2) CONTINUED SUSPENSION OF TRADING | 3 | HKEx | ||
| 05.12.24 | VENUS MEDTECH-B (02500): TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS | 1 | HKEx | ||
| 05.12.24 | VENUS MEDTECH-B (02500): TERMS OF REFERENCE OF THE REMUNERATION AND ASSESSMENT COMMITTEE OF THE BOARD OF DIRECTORS | 1 | HKEx | ||
| 05.12.24 | VENUS MEDTECH-B (02500): ARTICLES OF ASSOCIATION | - | HKEx | ||
| 05.12.24 | VENUS MEDTECH-B (02500): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 05.12.24 | VENUS MEDTECH-B (02500): POLL RESULTS OF THE 2024 SECOND EXTRAORDINARY GENERAL MEETING, 2024 SECOND CLASS MEETING OF HOLDERS OF H SHARES AND 2024 SECOND ... | - | HKEx | ||
| 22.11.24 | VENUS MEDTECH-B (02500): (1) THE FOURTH QUARTERLY UPDATE ON RESUMPTION PROGRESS; AND (2) CONTINUED SUSPENSION OF TRADING | 1 | HKEx | ||
| 19.11.24 | VENUS MEDTECH-B (02500): NOTIFICATION LETTER TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF CIRCULAR, PROXY FORM OF EXTRAORDINARY GENERAL MEETING ... | - | HKEx | ||
| 19.11.24 | VENUS MEDTECH-B (02500): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF CIRCULAR, PROXY FORM OF EXTRAORDINARY GENERAL MEETING ... | - | HKEx | ||
| 19.11.24 | VENUS MEDTECH-B (02500): PROXY FORM FOR USE AT THE 2024 SECOND CLASS MEETING OF HOLDERS OF UNLISTED FOREIGN SHARES | 2 | HKEx |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,660 | +2,13 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,470 | +1,27 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
| UNITEDHEALTH | 252,20 | +2,88 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 51,22 | +0,75 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
| KINDLY MD | 13,830 | 0,00 % | David Bailey and Bitcoin-Native Holding Company Nakamoto Announce Merger with KindlyMD to Establish Bitcoin Treasury | Raises $510 Million PIPE and $200 Million in Convertible Notes Marking Largest Capital Raise to Launch a Bitcoin Treasury and the Largest PIPE for Any Public Crypto-Related Transaction
David Bailey... ► Artikel lesen | |
| GENEDX | 63,73 | 0,00 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
| PROCEPT BIOROBOTICS | 58,15 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| NUTEX HEALTH | 174,34 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| DRAEGERWERK | 63,70 | +2,74 % | EQS-News: Drägerwerk AG & Co. KGaA: Hauptversammlung von Dräger beschließt Dividendenerhöhung - Aufnahme der Vorzugsaktien in den TecDAX | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Hauptversammlung/Dividende
Drägerwerk AG & Co. KGaA: Hauptversammlung von Dräger beschließt Dividendenerhöhung - Aufnahme der... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 0,270 | 0,00 % | Incannex Healthcare GAAP EPS of -$0.84, revenue of $0.08M | ||
| GERRESHEIMER | 60,55 | -2,65 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Nachhaltigkeit
Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab
12.05.2025... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 14,900 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| HIMS & HERS HEALTH | 53,16 | +1,45 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| BRIGHTSPRING HEALTH SERVICES | 24,020 | 0,00 % | IPO Stock Of The Week: Health Care Leader BrightSpring Poised To Hit New Buy Point | ||
| LIFEMD | 9,670 | 0,00 % | LifeMD, Inc.: LifeMD Reports Fourth Quarter 2024 Results | Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 millionTelehealth adjusted EBITDA increased 396% to $5.9 millionFull-year... ► Artikel lesen |
Das Unternehmen VENUS MEDTECH HANGZHOU INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS MEDTECH HANGZHOU INC finden Sie auf Wallstreet Online.